Palivizumab in infants with gestational age < or = 28 weeks and bronchopulmonary dysplasia. [electronic resource]
Producer: 20020927Description: 109-13 p. digitalSubject(s):- Analysis of Variance
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antiviral Agents -- administration & dosage
- Birth Weight
- Bronchopulmonary Dysplasia -- drug therapy
- Chi-Square Distribution
- Data Interpretation, Statistical
- Female
- Gestational Age
- Humans
- Infant
- Infant, Newborn
- Injections, Intramuscular
- Interviews as Topic
- Male
- Palivizumab
- Respiratory Syncytial Virus Infections -- prevention & control
- Surveys and Questionnaires
- Time Factors
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.